Aragon Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Aragon Pharmaceuticals Ownership

Who owns Aragon Pharmaceuticals?

Aragon Pharmaceuticals is owned by Johnson & Johnson. It was acquired on June 17, 2013.

Was Aragon Pharmaceuticals formerly PE-backed?

Yes. Aragon Pharmaceuticals was formerly owned by 1 private investor.

Aragon Pharmaceuticals Business Overview

Where is Aragon Pharmaceuticals headquartered?

Aragon Pharmaceuticals is headquartered in San Diego, California.

What sector is Aragon Pharmaceuticals in?

Aragon Pharmaceuticals is a life science company.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

Aragon Pharmaceuticals, Inc.

12780 El Camino Real Suite 301,
San Diego, California 92130
United States,
(858) 369-7600
www.aragonpharm.com

Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company focused on developing breakthrough medicines for the treatment of hormonally-driven cancers.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.